Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs

Nina NorgrenDepartment of Public Health and Clinical MedicineCorrespondence[email protected]

Malin OlssonDepartment of Public Health and Clinical Medicine

Hanna NyströmDepartment of Surgical and Perioperative Sciences, Umeå University UmeåSweden

Bo Göran EriczonDivision of Transplantation Surgery, Karolinska Institutet StockholmSweden

Marie de TayracCentre National de la Recherche Scientifique (CNRS), Unité mixte de recherché– UMR 6290, Institut Génétique et Développment de Rennes RennesFrance;Faculté de Médecine, Université Rennes 1, UEB – Université européenne de Bretagne Biosit, RennesFrance;CHU – Centre Hospitalier Universitaire de Rennes, Service de Génétique Moléculaire et Génomique RennesFrance

Emmanuelle GeninINSERM UMR1078 BrestFrance;CHRU BrestFrance

Violaine Planté-BordeneuveDepartment of Neurology, Reference Center for Neuromuscular Disease and Amyloidosis, Henri Mondor University Hospital CreteilFrance;INSERM UMR955-Team 10, Paris Est University ParisFrance

Ole B SuhrDepartment of Public Health and Clinical Medicine

show all

Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs

Supplementary Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs

Supplementary Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date